Rita O’connor
Chief Financial Officer
Pharmaceutical Technology
Plx Pharma
United States of America
Biography
Ms. O’Connor joined PLx as Chief Financial Officer effective July 1, 2017.Previously,She was the CFO and Chief Information Officer at Xanodyne Pharmaceuticals.Ms. O’Connor is a licensed certified public accountant and earned her Bachelor of Science in Accounting from Rutgers University.
Research Interest
Pharmaceutical Marketing
